Grey Matters Health Inc.

corporate_fare Company Profile

Grey Matters Health Inc.

AGNPF·OTC·Life Sciences·CIK 0001642178

Grey Matters Health Inc. is a clinical-stage pharmaceutical development company operating in Canada and Australia. The company is dedicated to developing therapeutic drugs for non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke. Its drug pipeline includes repirinast, which is being developed for the treatment of chronic kidney disease, and N,N-Dimethyltryptamine, which is being developed for the treatment of strokes and traumatic brain injuries. The company was incorporated in 2015 under its former name, Algernon Health Inc., and subsequently changed its name to Grey Matters Health Inc. in April 2026. Grey Matters Health Inc. is headquartered in Vancouver, Canada.

Grey Matters Health Inc. (OTC:AGNPF) is a publicly traded company in the Life Sciences sector. Wiseek monitors AGNPF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

Grey Matters Closes $1.25M Private Placement, Insiders Invest $449K (2026-06-18)
Grey Matters Closes CAD $500K First Tranche of Private Placement, Insiders Invest (2026-06-05)

Browse all tickers starting with A →

show_chartPrice Chart

Loading chart...

feed AGNPF - Latest Insights

Filing Type

Date Range

AGNPF

Jun 18, 2026, 7:00 AM EDT

Source: GlobeNewswire

Importance Score:

Grey Matters Closes $1.25M Private Placement, Insiders Invest $449K

Price at Filing: $0.355

Real-time Price: $0.29322

Change: Low Volume

Market Cap: $1.589M

Sentiment: Positive

View Wiseek Article